Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026

ESMO 2026 | 翰森制药公布瑞康立伏妥塔单抗（HS-20093）治疗复发或难治性骨肉瘤的III期ARTEMIS-011研究结果

ProclaimRx Launches The Next Generation Marketing Mix Modeling (MMM) Product for Commercial-Stage Biopharma Companies

RTI Researchers Introduce New Measure to Track Adverse Events Among Patients Starting Care at Opioid Treatment Programs

Mount Sinai Medical Center Physician Leads Global Phase 3 Trial Showing Chemotherapy-Free Treatment Improves Outcomes for Women with dMMR Endometrial Cancer